TrialBreast cancer research and treatment2021

Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).

Tufia C Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.